400 related articles for article (PubMed ID: 10651386)
41. Results of a multicenter prospective study on the postoperative treatment of unilateral retinoblastoma after primary enucleation.
Aerts I; Sastre-Garau X; Savignoni A; Lumbroso-Le Rouic L; Thebaud-Leculée E; Frappaz D; Coze C; Thomas C; Gauthier-Villars M; Lévy-Gabriel C; Brisse HJ; Desjardins L; Doz F
J Clin Oncol; 2013 Apr; 31(11):1458-63. PubMed ID: 23460706
[TBL] [Abstract][Full Text] [Related]
42. [Retinoblastoma update--therapy (Part II)].
Pogrzebielski A; Shields CL; Romanowska-Dixon B; Shields JA
Klin Oczna; 2006; 108(4-6):258-62. PubMed ID: 17020008
[TBL] [Abstract][Full Text] [Related]
43. [Retinoblastoma: preliminary results of national treatment protocol at Casablanca university medical center].
El Kettani A; Aderdour S; Daghouj G; Knari S; Zaghloul K; Zafad S; Harif M; Benchekroun S
J Fr Ophtalmol; 2014 Feb; 37(2):115-24. PubMed ID: 24507074
[TBL] [Abstract][Full Text] [Related]
44. Impact of chemoreduction for conservative therapy for retinoblastoma in Argentina.
Chantada GL; Fandiño AC; Schvartzman E; Raslawski E; Schaiquevich P; Manzitti J
Pediatr Blood Cancer; 2014 May; 61(5):821-6. PubMed ID: 24243706
[TBL] [Abstract][Full Text] [Related]
45. Results of a stage-based protocol for the treatment of retinoblastoma.
Schvartzman E; Chantada G; Fandiño A; de Dávila MT; Raslawski E; Manzitti J
J Clin Oncol; 1996 May; 14(5):1532-6. PubMed ID: 8622068
[TBL] [Abstract][Full Text] [Related]
46. Conservative treatments of intraocular retinoblastoma.
Lumbroso-Le Rouic L; Aerts I; Lévy-Gabriel C; Dendale R; Sastre X; Esteve M; Asselain B; Bours D; Doz F; Desjardins L
Ophthalmology; 2008 Aug; 115(8):1405-10, 1410.e1-2. PubMed ID: 18222001
[TBL] [Abstract][Full Text] [Related]
47. Enucleation vs Ophthalmic Artery Chemosurgery for Advanced Intraocular Retinoblastoma: A Retrospective Analysis.
Yannuzzi NA; Francis JH; Marr BP; Belinsky I; Dunkel IJ; Gobin YP; Abramson DH
JAMA Ophthalmol; 2015 Sep; 133(9):1062-6. PubMed ID: 26181236
[TBL] [Abstract][Full Text] [Related]
48. [Diagnosis and treatment of retinoblastoma: current strategies for effective tumour control and preservation of vision].
Temming P; Eggert A; Bornfeld N; Sauerwein W; Göricke S; Lohmann DR
Klin Monbl Augenheilkd; 2013 Mar; 230(3):232-42. PubMed ID: 23508752
[TBL] [Abstract][Full Text] [Related]
49. Chemoreduction for retinoblastoma: analysis of tumor control and risks for recurrence in 457 tumors.
Shields CL; Mashayekhi A; Cater J; Shelil A; Meadows AT; Shields JA
Trans Am Ophthalmol Soc; 2004; 102():35-44; discussion 44-5. PubMed ID: 15747743
[TBL] [Abstract][Full Text] [Related]
50. Treatment of Retinoblastoma: The Role of External Beam Radiotherapy.
Kim JY; Park Y
Yonsei Med J; 2015 Nov; 56(6):1478-91. PubMed ID: 26446627
[TBL] [Abstract][Full Text] [Related]
51. Microscopic scleral invasion in retinoblastoma: clinicopathological features and outcome.
Cuenca A; Giron F; Castro D; Fandiño A; Guitter M; de Dávila MT; Chantada G
Arch Ophthalmol; 2009 Aug; 127(8):1006-10. PubMed ID: 19667337
[TBL] [Abstract][Full Text] [Related]
52. Management of retinoblastoma with proximal optic nerve enhancement on MRI at diagnosis.
Armenian SH; Panigrahy A; Murphree AL; Jubran RF
Pediatr Blood Cancer; 2008 Oct; 51(4):479-84. PubMed ID: 18478574
[TBL] [Abstract][Full Text] [Related]
53. Intra-arterial chemotherapy for the management of retinoblastoma: four-year experience.
Gobin YP; Dunkel IJ; Marr BP; Brodie SE; Abramson DH
Arch Ophthalmol; 2011 Jun; 129(6):732-7. PubMed ID: 21320950
[TBL] [Abstract][Full Text] [Related]
54. Neoadjuvant/adjuvant treatment of high-risk retinoblastoma: a report from the German Retinoblastoma Referral Centre.
Künkele A; Wilm J; Holdt M; Lohmann D; Bornfeld N; Eggert A; Temming P; Schulte JH
Br J Ophthalmol; 2015 Jul; 99(7):949-53. PubMed ID: 25583279
[TBL] [Abstract][Full Text] [Related]
55. [Intraocular retinoblastoma: new therapeutic options].
Imhof SM; Moll AC; Schouten-van Meeteren AY
Ned Tijdschr Geneeskd; 2001 Nov; 145(45):2165-70. PubMed ID: 11727614
[TBL] [Abstract][Full Text] [Related]
56. Salvage external beam radiotherapy after failed primary chemotherapy for bilateral retinoblastoma: rate of eye and vision preservation.
Chan MP; Hungerford JL; Kingston JE; Plowman PN
Br J Ophthalmol; 2009 Jul; 93(7):891-4. PubMed ID: 19329423
[TBL] [Abstract][Full Text] [Related]
57. Intravenous and intra-arterial chemotherapy for retinoblastoma: what have we learned?
Shields CL; Kaliki S; Rojanaporn D; Al-Dahmash S; Bianciotto CG; Shields JA
Curr Opin Ophthalmol; 2012 May; 23(3):202-9. PubMed ID: 22450222
[TBL] [Abstract][Full Text] [Related]
58. Transpupillary thermotherapy as initial treatment for small intraocular retinoblastoma: technique and predictors of success.
Abramson DH; Schefler AC
Ophthalmology; 2004 May; 111(5):984-91. PubMed ID: 15121378
[TBL] [Abstract][Full Text] [Related]
59. Development of new retinoblastomas after 6 cycles of chemoreduction for retinoblastoma in 162 eyes of 106 consecutive patients.
Shields CL; Shelil A; Cater J; Meadows AT; Shields JA
Arch Ophthalmol; 2003 Nov; 121(11):1571-6. PubMed ID: 14609913
[TBL] [Abstract][Full Text] [Related]
60. Targeted retinoblastoma management: when to use intravenous, intra-arterial, periocular, and intravitreal chemotherapy.
Shields CL; Lally SE; Leahey AM; Jabbour PM; Caywood EH; Schwendeman R; Shields JA
Curr Opin Ophthalmol; 2014 Sep; 25(5):374-85. PubMed ID: 25014750
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
